For research and educational purposes only. Not medical advice.
Aviptadil Reference
Educational, not medical advice reference for Aviptadil: Sexual Health; regulatory status, evidence posture, source review, and schedule notes.…
Reference summary
Phase 2/3 trial data exist for inhaled aviptadil in respiratory failure and for intracavernosal use in ED. pepSmart displays aviptadil only as trial-context educational content.
Regulatory and posture
- Categories
- Sexual Health
- Aliases
- Synthetic vasoactive intestinal peptide, VIP analog, RLF-100
- Evidence posture
- human - Human trial data exist, but aviptadil remains investigational in the US - no FDA-approved drug label.
- Regulatory status
- Investigational in the United States. Aviptadil is a synthetic vasoactive intestinal peptide (VIP) analog studied investigationally for erectile dysfunction (intracavernosal Invicorp combination outside the US) and inhaled use in respiratory failure. There is no FDA-approved aviptadil drug label.
- Content review status
- investigational verified
Selected public sources
Related tools
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.
- Protocol builder overview - Public overview of the Pro protocol builder.